Villere St Denis J & Co LLC / LGND
Villere St Denis J & Co LLC’s Ligand Pharmaceuticals Inc Position
Does Villere St Denis J & Co LLC own Ligand Pharmaceuticals Inc (LGND)? Yes — 188.9K shares worth $38M (+4.16% of its 13F portfolio) as of Q1 2026, down from 202.5K shares the prior filed quarter.
Position Value
$38M
Q1 2026
Shares
188.9K
% of Portfolio
+4.16%
Quarters Held
25
currently held
Position History LGND
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 188.9K | $38M | +4.16% |
| Q4 2025 | 202.5K | $38M | +3.84% |
| Q3 2025 | 279.9K | $50M | +4.77% |
| Q2 2025 | 287.1K | $33M | +3.14% |
| Q1 2025 | 288.8K | $30M | +2.93% |
| Q4 2024 | 287.0K | $31M | +2.78% |
| Q3 2024 | 474.9K | $48M | +3.88% |
| Q2 2024 | 483.9K | $41M | +3.45% |
| Q1 2024 | 490.8K | $36M | +2.86% |
| Q4 2023 | 428.1K | $31M | +2.52% |
| Q3 2023 | 438.2K | $26M | +2.24% |
| Q2 2023 | 479.4K | $35M | +2.50% |
| Q1 2023 | 480.8K | $35M | +2.57% |
| Q4 2022 | 483.3K | $32,287 | +2.52% |
| Q3 2022 | 491.1K | $42M | +3.37% |
| Q2 2022 | 496.0K | $44M | +3.31% |
| Q1 2022 | 510.8K | $57M | +3.41% |
| Q4 2021 | 519.0K | $80M | +4.60% |
| Q3 2021 | 564.3K | $79M | +4.58% |
| Q2 2021 | 594.4K | $78M | +4.18% |
| Q1 2021 | 537.0K | $82M | +4.48% |
| Q4 2020 | 642.1K | $64M | +3.85% |
| Q3 2020 | 663.4K | $63M | +4.25% |
| Q2 2020 | 647.7K | $72M | +5.19% |
| Q1 2020 | 635.8K | $46M | +3.94% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Villere St Denis J & Co LLC’s full portfolio or all institutional holders of LGND.